Salmon ( DrugBank: Salmon )

3 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	1
97	Ulcerative colitis	2
225	Congenital nephrogenic diabetes insipidus	1

96. Crohn disease

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00114803 (ClinicalTrials.gov)	January 2004	17/6/2005	Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease	Use of Intranasally Administered Calcitonin in the Treatment of Osteopenia and Osteoporosis in Children, Adolescents and Young Adults With IBD: A Pilot Study	Ulcerative Colitis;Crohn's Disease	Drug: Calcitonin nasal spray (salmon)	Children's Hospital Boston	Crohn's and Colitis Foundation;National Institutes of Health (NIH)	Completed	8 Years	22 Years	Both	66	N/A	United States

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00751933 (ClinicalTrials.gov)	October 2008	11/9/2008	Vaccines and Dietary Oats in the Treatment of Ulcerative Colitis	A Controlled Study of Salmonella Ty21a and Cholera/ ETEC-vaccine and the Role of Oats in Daily Diet as a New Treatment in Patients With Mild or Moderate Ulcerative Colitis.	Ulcerative Colitis	Biological: Vaccine Vivotif + Vaccine Dukoral + oats;Biological: Vaccine Vivotif + Vaccine Dukoral;Dietary Supplement: Oats;Other: Placebo	Haukeland University Hospital	Helse Vest	Terminated	18 Years	80 Years	All	3	Phase 2	Norway
2	NCT00114803 (ClinicalTrials.gov)	January 2004	17/6/2005	Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease	Use of Intranasally Administered Calcitonin in the Treatment of Osteopenia and Osteoporosis in Children, Adolescents and Young Adults With IBD: A Pilot Study	Ulcerative Colitis;Crohn's Disease	Drug: Calcitonin nasal spray (salmon)	Children's Hospital Boston	Crohn's and Colitis Foundation;National Institutes of Health (NIH)	Completed	8 Years	22 Years	Both	66	N/A	United States

Clinical trials : 15 / Drugs : 48 - (DrugBank : 18) / Drug target genes : 31 - Drug target pathways : 65

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-003360-56-DK (EUCTR)	28/08/2009	07/07/2009	Farmakologisk behandling af CNDI – Et ”proof-of-concept” studie. - NDI-POC-STUDY	Farmakologisk behandling af CNDI – Et ”proof-of-concept” studie. - NDI-POC-STUDY	Kongenit nefrogen diabetes insipidus MedDRA version: 14.1;Level: PT;Classification code 10068304;Term: Congenital nephrogenic diabetes insipidus;System Organ Class: 10010331 - Congenital, familial and genetic disorders	Trade Name: Confortid INN or Proposed INN: INDOMETACIN Trade Name: Losec INN or Proposed INN: OMEPRAZOLE MAGNESIUM Trade Name: Viagra Other descriptive name: SILDENAFIL CITRATE Trade Name: Miacalcic Other descriptive name: CALCITONIN (SALMON) Trade Name: Spirix Other descriptive name: SPIRONOLACTONE Trade Name: Esidrix Product Name: Esidrix INN or Proposed INN: HYDROCHLOROTHIAZIDE	Dept. of Pediatrics, The Childrens Hospital, Denver	NULL	Not Recruiting			Female: no Male: yes	40		Denmark